Author

Henry J. Durivage

Observed names: Durivage, Henry, H Durivage, H J Durivage, H. Durivage, H. J. Durivage, Henry Durivage

Observed institutions: Yale New Haven Hospital, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of Connecticut, University of Louisville, Yale Cancer Center, Yale University, VA Connecticut Healthcare System, Theradex Oncology (United States), Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Rutgers Cancer Institute

OpenAlex ID: A5020404202

The Cancer Chemotherapy Handbook

2004 · David S. Fischer, M. Tish Knobf, et al. · International Journal of Gynecological Cancer · 151

Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial

2016 · Vincent Chung, Aaron S. Mansfield, et al. · Clinical Cancer Research · 128

The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.

1991 · J C Marsh, J R Bertino, et al. · Journal of Clinical Oncology · 103

Cyclosporine treatment of refractory T-cell lymphomas

1993 · Dennis L. Cooper, Irwin M. Braverman, et al. · Cancer · 49

PDF

Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer

1996 · J. R. Murren, Henry J. Durivage, et al. · Cancer Chemotherapy and Pharmacology · 37

A phase II study of irinotecan (CPT‐11) in patients with advanced squamous cell carcinoma of the cervix

1998 · William P. Irvin, Fredric V. Price, et al. · Cancer · 36

Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine

1989 · William N. Hait, Steve Morris, et al. · Cancer Chemotherapy and Pharmacology · 33

High‐dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma

1991 · Antonio C. Buzaid, John R. Murren, et al. · Cancer · 23

High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma

1991 · John R. Murren, William Derosa, et al. · Cancer · 23

PDF

The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomas.

1990 · W N Hait, T N Byrne, et al. · PubMed · 19

Metastatic breast cancer: preliminary results with oral hormonal therapy.

1985 · J C Allegra, J Bertino, et al. · PubMed · 17

Clinical trial metrics: Protocol performance and resource utilization from 14 cancer centers

2009 · H. J. Durivage, K. D. Bridges · Journal of Clinical Oncology · 13

High-dose cisplatin plus WR-2721 in a split course in metastatic malignant melanoma. A phase II study.

1991 · A C Buzaid, J Murren, et al. · PubMed · 11

Preliminary Results from a Phase 1b Dose De-Escalation Stage of Abnl-Marro 001: An International MDS/MPN Working Group Study

2023 · Ashwin Kishtagari, Melissa A Fischer, et al. · Blood · 7

High time for low‐dose prospective clinical trials

2003 · Robert S. DiPaola, Henry J. Durivage, et al. · Cancer · 7

A Phase I Pilot Study of BCNU plus Thymidine in Patients with Refractory Cancer

1996 · Michelle Z. Schultz, Alan B. Sandier, et al. · Cancer Investigation · 5

A Phase II Trial of Cyclosporin A in the Treatment of Refractory Metastatic Colorectal Cancer

1991 · John R. Murren, Sanjay Ganpule, et al. · American Journal of Clinical Oncology · 4

Protocol performance metrics and resource utilization of phase II investigator-initiated trials.

2010 · H. Durivage, K. D. Bridges, et al. · Journal of Clinical Oncology · 2

Phase II Study of Pulse 5-Fluoro-2′-Deoxyuridine and Leucovorin in Advanced Colorectal Cancer Patients Previously Treated with Chemotherapy

1992 · John C. Marsh, Henry J. Durivage, et al. · American Journal of Clinical Oncology · 2

Prevention and Management of Toxicities Associated With Antineoplastic Drugs

1991 · Henry J. Durivage, Nora L. Burnham · Journal of Pharmacy Practice · 2

A phase II salvage trial of transdermal estradiol in the treatment of hormone and chemotherapy refractory prostate cancer: A Cancer Institute of New Jersey Oncology Group Study NJ1803

2004 · N. Morganstein, S. Doyle-Lindrud, et al. · Journal of Clinical Oncology · 1

Anti-estrogen therapy for breast cancer: focus on tamoxifen.

1982 · K T Flynn, H J Durivage · PubMed · 1

Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer

2010 · Moss, Rebecca A., Moore, Dirk, et al. · Europe PMC (PubMed Central)

Cisplatin, Doxorubicin, Mitomycin C, and 5-Fluorouracil for the Treatment of Metastatic Non-Small Cell Lung Cancer

1994 · John R. Murren, Henry J. Durivage, et al. · American Journal of Clinical Oncology

A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.

1993 · J R Murren, S Ganpule, et al. · PubMed

Works count: 25

Citation count: 674

H-index: 12

I10-index: 13